Among all leukemia subtypes, CD33 exhibited a robust enrichment in AML and CML (chronic myelogenous leukemia), while IL1B correlated best with pediatric ALL and considerably with AML (Figure 7D). This evidence concerns the gene CD33 and leukemia.